Document is current
Any future updates will be listed below
-
Authors
Agarwal, Gina https://orcid.org/0000-0002-5691-4675
Angeles, Ricardo N.
Dolovich, Lisa
Kaczorowski, Janusz
Gaber, Jessica
Guenter, Dale
Arnuco, Floro Dave
Lam, Hilton Y.
Thabane, Lehana
O’Reilly, Daria
Agbulos, Rodelin M.
Arciaga, Rosemarie S.
Barrera, Jerome
Gregorio, Elgie
Halili, Servando Jr
Jalani, Norvie
Cristobal, Fortunato
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (139438)
International Development Research Centre (107826-001)
- License Information
-
More Information
Article History
Received: 27 February 2019
Accepted: 14 May 2019
First Online: 3 June 2019
Ethics approval and consent to participate
: This trial and all materials (consent, database, education materials) has obtained ethics approval from the Ateneo de Zamboanga (ADZU) research ethics board, Philippines (approval #2018-SM-0001), and the Hamilton Integrated Research Ethics Board (HiREB), Canada (project ID #4303). Any amendments regarding protocol changes will be submitted to both ethical review boards. The trial is also registered with ClinicalTrials.gov (identifier NCT03481335, first posted March 29, 2018; last updated August 17, 2018). Signed, written, informed consent will be obtained from study participants in all groups prior to participation in elements of the study. To maintain confidentiality, data will be de-identified prior to analysis. The data that is collected will only be made available for review by authorized persons including CHAP-P research team in the Philippines and Canada, institutional review boards, and transcriber of the focus groups. Information stored on computers will be protected by a password. Information stored on paper will be kept in locked cabinets.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
